Hormonal Contraception Without Ethinylestradiol: Hopes, Potentials, and Prospects
This article reviews published works that describe Russian clinical experience with Qlaira (estradiol valerate/dienogest), an innovative combined oral contraceptive. These publications also detail the medical, social, clinical and pharmacological issues related to the use of this agent in Russian gynecological patients, present evidence-based data and outline the prospects for this method of contraception in Russia. The authors also summarize information on dosing regimens for this pill and provide more precise data on the levels of evidence regarding its efficacy and safety.